SCHEMBL875181

SCHEMBL875181

CCCCCOC(=O)CCC(C)=O

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 1/20 0.62
NAAA Q02083 1/20 0.61
DGKA P23743 1/20 0.61
RAD52 P43351 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
PRSS1 P07477 1/20 0.51
PRSS2 P07478 1/20 0.51
PRSS3 P35030 1/20 0.51
TSHR P16473 2/20 0.50
ALDH1A1 P00352 1/20 0.50
FAAH O00519 1/20 0.50
DNM1 Q05193 1/20 0.50
CES2 O00748 1/20 0.48
EPHX1 P07099 1/20 0.47
PAM P19021 2/20 0.46
EPHX2 P34913 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3714189 0.98 HTR2C (0.66) HTR2CNAAADGKARAD52NPSR1
SCHEMBL3713746 0.98 HTR2C (0.66) HTR2CNAAADGKARAD52NPSR1
SCHEMBL11214363 0.98 HTR2C (0.66) HTR2CNAAADGKARAD52NPSR1
SCHEMBL1685026 0.98 HTR2C (0.66) HTR2CNAAADGKARAD52NPSR1
SCHEMBL16837098 0.98 HTR2C (0.66) HTR2CNAAADGKARAD52NPSR1
SCHEMBL3154151 0.98 HTR2C (0.66) HTR2CNAAADGKARAD52NPSR1
SCHEMBL12075380 0.98 HTR2C (0.66) HTR2CNAAADGKARAD52NPSR1
SCHEMBL3714353 0.98 HTR2C (0.66) HTR2CNAAADGKARAD52NPSR1
SCHEMBL118152 0.94 ALDH1A1 (0.58) HTR2CNAAADGKARAD52NPSR1
Hexane SCHEMBL1882910 0.92 DGKA (0.61) HTR2CNAAADGKARAD52NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 204 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250040543-A1 Preservative Composition Arxada Switzerland AG (CH) 2025-02-06 US claimed
CN-119118964-A Comprehensive utilization method of rectification heavy component of 2-methyl furan byproduct 濮阳宏业高新科技发展有限公司 2024-12-13 CN claimed
CN-118234379-A Preservative composition 阿尔萨达股份公司 2024-06-21 CN claimed
EP-4380360-A1 PRESERVATIVE COMPOSITION Arxada AG (CH) 2024-06-12 EP claimed
WO-2023084103-A1 PRESERVATIVE COMPOSITION ARXADA AG (CH) 2023-05-19 WO claimed
CN-111253263-B Preparation method of chloroquine key intermediate 2-amino-5-diethylaminopentane 北京弗莱明科技有限公司 2022-07-05 CN claimed
CN-111253263-A Preparation method of chloroquine key intermediate 2-amino-5-diethylamino pentane 北京弗莱明科技有限公司 2020-06-09 CN claimed
CN-105669456-A Method for preparing valerate from levulinic acid 中国科学院兰州化学物理研究所 2016-06-15 CN claimed
EP-1685217-B1 FUEL COMPOSITIONS COMPRISING A C4-C8 ALKYL LEVULINATE SHELL INT RESEARCH (NL) 2012-12-12 EP claimed
CN-101233216-A Fuel compositions SHELL INT RESEARCH (NL) 2008-07-30 CN claimed
US-20070094919-A1 Fuel compositions SHELL OIL COMPANY 2007-05-03 US claimed
WO-2007012585-A1 FUEL COMPOSITIONS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2007-02-01 WO claimed
WO-2007012586-A1 FUEL COMPOSITIONS SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2007-02-01 WO claimed
CN-1894230-A Process for liquefying lignocellulosic material SHELL INT RESEARCH (NL) 2007-01-10 CN claimed
CN-1886488-A Fuel compositions comprising a c4-c8 alkyl levulinate SHELL INT RESEARCH (NL) 2006-12-27 CN claimed
EP-1699771-A1 A PROCESS FOR THE LIQUEFACTION OF LIGNOCELLULOSIC MATERIAL SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 2006-09-13 EP claimed
EP-1685217-A1 FUEL COMPOSITIONS COMPRISING A C4-C8 ALKYL LEVULINATE SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 2006-08-02 EP claimed
US-20050144835-A1 Fuel compositions SHELL OIL COMPANY 2005-07-07 US claimed
WO-2005058856-A1 A PROCESS FOR THE LIQUEFACTION OF LIGNOCELLULOSIC MATERIAL SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2005-06-30 WO claimed
WO-2005044960-A1 FUEL COMPOSITIONS COMPRISING A C4-C8 ALKYL LEVULINATE SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2005-05-19 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250040543-A1 Preservative Composition PHOSPHO1, PSEN1, PSEN2 HTR2C 2408/4885NAAA 959/4885DGKA 2847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.